Navigation Links
ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
Date:12/6/2012

HOLLYWOOD, FL and EVANSTON, IL, December 6, 2012 -- Naurex Inc., a clinical stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13. GLYX-13 is a novel partial agonist of the NMDA receptor. The Phase Ila results are being presented this week at the 51st Annual Meeting of the American College of Neuropsychopharmacology (ACNP).

The Phase IIa results show that a single administration of GLYX-13 produced statistically significant reductions in depression scores in subjects who had failed treatment with one or more antidepressant agents. The reductions were evident within 24 hours and persisted for an average of seven days. Importantly, the effect size, a measure of the magnitude of the drug's antidepressant efficacy, observed at 24 hours and at seven days after a single administration of GLYX-13, was nearly double the effect size seen with most other antidepressant drugs after 4-6 weeks of repeated dosing.

In the Phase IIa trial, GLYX-13 was well tolerated. Reported side effects were mild to moderate and were consistent with those observed in subjects receiving placebo. Consistent with previous studies, GLYX-13 did not produce any of the schizophrenia-like psychotomimetic effects associated with other drugs that modulate the NMDA receptor.

"These data are an important step in validating Naurex's mission of developing breakthrough therapies for depression and other CNS disorders," said Derek Small, CEO of Naurex. "Our founder discovered a new class of drugs that appeared to have the remarkable antidepressant efficacy of ketamine-like compounds, but without their limiting side effects. These Phase II results suggest that this discovery may translate into measurable health improvements for individuals with depression, which bodes well for the future success of GLYX-13 and the other p
'/>"/>

Contact: Barbara Lindheim
blindheim@bllbiopartners.com
917-355-9234
BLL Partners, LLC
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
2. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
3. Novel breast screening technology increases diagnostic accuracy
4. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
5. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
6. Novel treatment strategies for epilepsy
7. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
8. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
9. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
10. Moffitt cancer center researchers find novel predictor for MDS progression risk
11. Novel surgery removes rare tumor, rebuilds face and jaw
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
(Date:12/25/2014)... 25, 2014 Helen Harris’ RP (Retinitis ... Hills, California after an 8 year battle with breast ... Eve evening in her home in Woodland Hills California ... cancer. , As the founder and ... she pioneered and championed many of today's greatest breakthroughs ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
(Date:12/25/2014)... 25, 2014 Residents at ... recently showed their generous spirit by providing holiday ... County Parenting Network- Grandparents Raising Grandchildren program. , ... around the largest Christmas tree on the campus ... by residents of the Abernethy Village Association (AVA). ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... ... Rockettes in Vienna for the 2010 Life Ball on July 17th, 2010 , ... New York, NY (PRWEB) June 30, 2010 -- Diane von ... Vienna for the 2010 Life Ball on July 17th, 2010., , ,“There is nothing more New ...
... MD, PhD, a physician-scientist in the Hematology/Oncology Divison at ... Medicine at Harvard Medical School has received a Young ... three-year $225,000 award, one of 21 made to young ... to encourage the most innovative minds in cancer research ...
... are 5 years and younger living in Tanzania. ... make a positive and significant impact on what these ... the Tanzanian version of Sesame Street, recently commissioned researchers ... in full collaboration with a Dar es Salaam-based research ...
... Scientists at the Stanford University School of Medicine have ... is significant because the existence of such a cell ... of debate. It may also explain why current immunotherapies ... patients. "These cells lack the traditional melanoma ...
... ... luctus mollis. Aenean cursus, nisi id congue convallis, risus augue pulvinar sem, nec ultricies ... lectus. In placerat eleifend felis in commodo. , ... Freistatt, MO (PRWEB) June 30, 2010 -- Lorem ipsum ...
... HealthDay Reporter , WEDNESDAY, June 30 (HealthDay News) ... significant potential, even as the disease,s looming impact on society ... scientists, in fact, worry that we may not be doing ... into Alzheimer,s, the most common type of dementia among older ...
Cached Medicine News:Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 2Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 3Health News:BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation 2Health News:Kilimani Sesame has positive impact on children in Tanzania: Johns Hopkins University study 2Health News:Melanoma-initiating cell identified by Stanford scientists 2Health News:Melanoma-initiating cell identified by Stanford scientists 3Health News:Melanoma-initiating cell identified by Stanford scientists 4Health News:Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce ornare dictum nunc 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 3Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 4
(Date:12/24/2014)... 24, 2014  Commonwealth Cornerstone Group (CCG) today announced the ... on Tuesday to help fund the expansion and consolidation of ... Sharon . PHN is the ... . It is the largest employer in ... people on staff. Currently, PHN Sharon offers scattered ...
(Date:12/24/2014)...  Conkwest, Inc., the Natural Killer Cell Company ... (NK) cell-line platform, Neukoplast® (NK-92™) as an immuno-oncology ... NantWorks founder, physician scientist and biotechnology entrepreneur, has ... $48 million of the Company,s Class A Common ... be named Co-Chairman of the Conkwest Board of ...
(Date:12/24/2014)... 23, 2014 Echo Therapeutics, Inc. (NASDAQ: ... focused on skin permeation, continuous glucose monitoring and ... Hollander has been appointed Chief Executive Officer ... than 20 years of experience in the medical ... recently served as Vice President, Business Development, Otsuka ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... , WESTWOOD, Mass., Dec. 7 CompuCyte ... instrumentation and the leading supplier of laser scanning cytometers, ... line of imaging cytometers to include four-laser versions of ... of four excitation lasers chosen from a palette of ...
... EDISON, N.J., Dec. 7 Q-Med AB and Oceana Therapeutics, Inc. ... primary endpoints for the treatment of fecal incontinence. , Q-Med AB ... the FDA during the first quarter of 2010 based on the ... result of years of hard work as we developed a product ...
Cached Medicine Technology:CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
The Nicolet Bravo is a Multi-application system that can configure to meet the needs of neurophysiology deparent....
... Portable systems of the MYOHANDY ... units of the MYOQUICK - SystemPLUS ... they use acquisition systems of the ... channels (ISA 1002, ISA 1002 EP) ...
... Multi-channels Evoked Potential testing systems are the point ... and shows the extremely high technology level of ... channels headbox BQ 132S combined with Acquisition / ... headboxes: ISA 1002 EP with 2 channels, ISA ...
Medicine Products: